Tasly Pharmaceutical Group Co., Ltd (SHA: 600535)

China flag China · Delayed Price · Currency is CNY
14.30
-0.20 (-1.38%)
Sep 6, 2024, 3:00 PM CST
3.32%
Market Cap 21.36B
Revenue (ttm) 8.65B
Net Income (ttm) 1.03B
Shares Out 1.49B
EPS (ttm) 0.69
PE Ratio 20.78
Forward PE 14.74
Dividend 0.52 (3.64%)
Ex-Dividend Date May 29, 2024
Volume 10,669,850
Open 14.50
Previous Close 14.50
Day's Range 14.30 - 14.55
52-Week Range 12.24 - 18.00
Beta 0.37
Analysts n/a
Price Target n/a
Earnings Date Oct 28, 2024

About Tasly Pharmaceutical Group

Tasly Pharmaceutical Group Co., Ltd engages in the pharmaceutical business in China and internationally. It provides cardiovascular, anti-tumor, cold and fever, liver disease treatment, and other disease solutions. Tasly Pharmaceutical Group Co., Ltd was founded in 1994 and is based in Tianjin, China. [Read more]

Sector Healthcare
Founded 1994
Employees 9,223
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600535
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.